Target intelligence / Profile preview

RNA, U1 small nuclear 112, pseudogene (RNU1-112P)

Target
RNU1-112P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RNU1-112P (RNA, U1 small nuclear 112, pseudogene) is classified as a pseudogene of the U1 small nuclear RNA (snRNA) family[1][4]. Pseudogenes are nonfunctional copies of gene sequences that usually do not encode functional products. Unlike active U1 snRNA genes (such as RNU1-1, which is essential for pre-mRNA splicing), RNU1-112P does not produce a functionally active RNA and does not participate in known biological processes or pathways[1][4][2]. There is currently no evidence linking RNU1-112P to disease, drug interaction, or use as a biomarker. Its main utility is as a genomic reference for evolutionary and structural analyses within snRNA gene families and pseudogenes. Key context and clarification: - Not a therapeutic target: RNU1-112P is a noncoding RNA pseudogene; there is no evidence it encodes a protein or functional RNA, nor is it targeted by any drugs, used in therapy, or considered a disease or cellular function modulator[1][4]. - Pseudogene status: Unlike functional U1 small nuclear RNA genes (such as RNU1-1 or RNU1-2), which are required for spliceosome function and gene expression regulation[2][3][6], RNU1-112P is annotated as a nonfunctional locus and does not contribute to molecular or cellular activity. - Is_incorrect: If the intent is to identify a therapeutic or biologically relevant RNA target, then "RNU1-112P" is not appropriate—this is a pseudogene, not a functional receptor, enzyme, or other canonical drug target. For structured curation, almost all fields return null except for name, class, and explicit note that it is a pseudogene and not a target.

Other names
RNU1-112PRNA U1 small nuclear 112 pseudogeneU1 snRNA pseudogene 112

Beyond the preview

Go deeper on RNA, U1 small nuclear 112, pseudogene (RNU1-112P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 112, pseudogene (RNU1-112P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call